...KRAS), which has been implicated as a regulator of cell proliferation, differentiation and transformation, was identifie...
...KRAS mutation analysis was performed in the primary tumor tissues and KRAS mutations were identified in 47.6% of the pat...
...KRAS mutations within the same tumor specimen have not been reported. The present study describes the case of a treatmen...
...KRAS, BRAF and HER2; and detected ALK, ROS1 and RET rearrangements. Gene amplification and expression of EGFR, human epi...
...KRAS and BRAF status in 159 colorectal cancer samples obtained from the University of Tirana.,We evaluated KRAS mutation...
...Kras and TNFα was increased in the pancreas, indicating that Aroclor 1254 exposure could result in increased risk of inf...
...KRAS or BRAF mutations. While efficacy signals have been seen in various tumor types treated with selumetinib, better bi...
...KRAS) and more recently, neuroblastoma RAS viral oncogene (NRAS) mutations in CRC has changed the focus of therapy for m...
...KRAS in carcinoma provide a rationale and several possible routes to the development of therapies. Tumors with both p53-...
...KRAS mutations. The frequency of KRAS mutation was not associated with age, gender, or smoking history. The number of pa...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
